Microgynon 30 contraceptive pill

Microgynon 30 is a widely used combined oral contraceptive pill containing levonorgestrel and ethinylestradiol. It is one of the most established hormonal birth control brands globally, known for its reliability in preventing pregnancy when taken correctly. The brand is synonymous with high-quality pharmaceutical standards and woman-centric healthcare solutions.

Originally developed by the German pharmaceutical giant Schering AG, the brand joined the Bayer portfolio following Bayer's acquisition of Schering in 2006. This merger solidified Bayer's position as a global leader in women's healthcare. Today, the product is manufactured in several high-tech pharmaceutical facilities across Europe and South America to meet global demand, while maintaining headquarters in Leverkusen, Germany.

Bayer AG continues to be the ultimate owner, managing the brand through its Pharmaceuticals division. The company is a multinational conglomerate with a significant legacy in life sciences, including healthcare and agriculture. In local markets like the United Kingdom, it is managed by Bayer plc, the regional subsidiary responsible for distribution and regulatory compliance.